Monashee Investment Management »

Bridgebio Pharma shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 60k 30.92
2019-06-30 $1.3M 50k 26.98

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Aercap Holdings Nv SHS (AER)
Birkenstock Holding Com Shs (BIRK)
Ares Management Corporation Cl A Com Stk (ARES)
Dell Technologies CL C (DELL)
Corebridge Finl (CRBG)
Advanced Micro Devices (AMD)
Kenvue (KVUE)

View all positions for Monashee Investment Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
Aisling Capital Management
State Street Corporation
Susquehanna International
Laurion Capital Management
Henderson Group
Frazier Life Sciences Management
Geode Capital Management
Citadel Advisors
Alliancebernstein
Goldman Sachs Group
Cormorant Asset Management

View all funds holding Bridgebio Pharma